Choksi Laboratories Limited (BOM:526546)
India · Delayed Price · Currency is INR 111.15
-9.60 (-7.95%)
At close: Feb 13, 2026
Choksi Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 445.85 | 417.82 | 366.95 | 344.41 | 300.42 | 256.88 | |
Revenue Growth (YoY) | 7.43% | 13.86% | 6.55% | 14.64% | 16.95% | -8.77% |
Cost of Revenue | 216.79 | 200.75 | 171.08 | 155.95 | 139.93 | 140.66 |
Gross Profit | 229.06 | 217.08 | 195.87 | 188.46 | 160.49 | 116.22 |
Selling, General & Admin | 5.66 | 5.66 | 6.02 | 5.33 | 3.22 | 5.02 |
Other Operating Expenses | 101.62 | 96.95 | 86.07 | 78.86 | 66.8 | 68.38 |
Operating Expenses | 178.28 | 169.59 | 150.74 | 141.03 | 125.83 | 121.01 |
Operating Income | 50.78 | 47.48 | 45.13 | 47.43 | 34.67 | -4.79 |
Interest Expense | -26.95 | -26.6 | -30.07 | -34.94 | -32.12 | -27.97 |
Interest & Investment Income | 1.98 | 0.6 | 1.64 | 1.97 | 1.16 | 4.4 |
Currency Exchange Gain (Loss) | 0.17 | 0.06 | -0.02 | 0.2 | -0.07 | -0.21 |
Other Non Operating Income (Expenses) | -0.23 | - | - | - | -0 | 0.4 |
EBT Excluding Unusual Items | 25.75 | 21.54 | 16.68 | 14.66 | 3.64 | -28.16 |
Gain (Loss) on Sale of Assets | -0 | -0 | -0.05 | -0.01 | 0.04 | 0.08 |
Other Unusual Items | 7.78 | - | - | 22.56 | - | - |
Pretax Income | 33.53 | 21.53 | 16.63 | 37.21 | 3.67 | -28.08 |
Income Tax Expense | 14.94 | 6.3 | 5.53 | 5.11 | 1.6 | -2.01 |
Net Income | 18.59 | 15.23 | 11.1 | 32.1 | 2.07 | -26.08 |
Net Income to Common | 18.59 | 15.23 | 11.1 | 32.1 | 2.07 | -26.08 |
Net Income Growth | 44.69% | 37.26% | -65.43% | 1450.73% | - | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Change (YoY) | -0.58% | - | - | - | - | -0.00% |
EPS (Basic) | 2.68 | 2.19 | 1.59 | 4.61 | 0.30 | -3.74 |
EPS (Diluted) | 2.68 | 2.19 | 1.59 | 4.61 | 0.30 | -3.74 |
EPS Growth | 45.80% | 37.55% | -65.50% | 1450.73% | - | - |
Free Cash Flow | - | 43.39 | 45.47 | 43.01 | 51.98 | -21.59 |
Free Cash Flow Per Share | - | 6.23 | 6.53 | 6.17 | 7.46 | -3.10 |
Gross Margin | 51.38% | 51.95% | 53.38% | 54.72% | 53.42% | 45.24% |
Operating Margin | 11.39% | 11.36% | 12.30% | 13.77% | 11.54% | -1.86% |
Profit Margin | 4.17% | 3.65% | 3.02% | 9.32% | 0.69% | -10.15% |
Free Cash Flow Margin | - | 10.38% | 12.39% | 12.49% | 17.30% | -8.40% |
EBITDA | 111.61 | 106.73 | 102.27 | 102.41 | 88.94 | 41.24 |
EBITDA Margin | 25.03% | 25.54% | 27.87% | 29.73% | 29.61% | 16.05% |
D&A For EBITDA | 60.83 | 59.25 | 57.14 | 54.98 | 54.28 | 46.03 |
EBIT | 50.78 | 47.48 | 45.13 | 47.43 | 34.67 | -4.79 |
EBIT Margin | 11.39% | 11.36% | 12.30% | 13.77% | 11.54% | -1.86% |
Effective Tax Rate | 44.56% | 29.26% | 33.27% | 13.74% | 43.60% | - |
Revenue as Reported | 447.79 | 418.49 | 368.59 | 346.58 | 301.62 | 261.76 |
Advertising Expenses | - | 0.28 | 0.99 | 1.15 | 0.15 | 0.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.